Recombinant CD276 (Enoblituzumab Biosimilar) antibody

Catalog No. ABIN7488091

The Mammalian Cells Monoclonal anti-CD276 (Enoblituzumab Biosimilar) antibody has been validated for . It is suitable to detect CD276 (Enoblituzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD276 (Enoblituzumab Biosimilar) antibody (ABIN7488091)

Target: CD276 (Enoblituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Grade: Research Grade

Product Details anti-CD276 (Enoblituzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD276 (Enoblituzumab Biosimilar)

Target: CD276 (Enoblituzumab Biosimilar)

Target Type: Biosimilar

Background: MG-A271